潮汕夫妇做保健品年入42亿，A股市值近72亿，正冲击港股IPO！

Core Viewpoint - Xianle Health Technology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, aiming to enhance its global strategy and capital strength [2][5]. Company Overview - Established in 1993 and headquartered in Shantou, Guangdong, Xianle Health is one of China's large contract manufacturers in the nutrition and health food sector [4]. - The company covers the entire service chain from product research and development to manufacturing, packaging, and marketing [4]. Market Position - If the Hong Kong listing is successful, Xianle Health is expected to become the first A+H listed company in the nutrition and health industry [5]. - According to data from Zhaoshang Consulting, Xianle Health holds the third-largest market share in the global nutrition and health food solutions market and ranks first in China [7]. Financial Performance - Revenue for 2023, 2024, and the first nine months of 2025 is projected at RMB 3.582 billion, RMB 4.211 billion, and RMB 3.291 billion, respectively [8][9]. - Net profit for the same periods is expected to be RMB 240.3 million, RMB 282.0 million, and RMB 55.5 million, with gross profit margins of 29.7%, 30.6%, and 31.5% [8][9]. - The company anticipates a significant decline in net profit for 2025, projecting a decrease of 53% to 69% compared to the previous year [10]. Shareholding Structure - Major shareholders include Lin Peiqing, Chen Qiong, Guanghui Investment, and Abama Enjoy Dividend No. 96, collectively holding approximately 59.24% of the company's total issued share capital [10][12]. Board of Directors - The board consists of nine members, including three executive directors, two non-executive directors, and four independent non-executive directors [13]. - Lin Peiqing serves as the executive director and chairman, while Chen Qiong is the executive director and vice president [16][18]. Stock Performance - As of January 30, the stock price of Xianle Health was reported at RMB 23.40, with a total market capitalization of RMB 7.199 billion [19][20].